Across the recent three months, 14 analysts have shared their insights on Johnson & Johnson JNJ, expressing a variety of ...

The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...

Skorzewiak/Shutterstock Lawsuit filed in a California court on Thursday (September 5) alleges that Johnson & Johnson used APM ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Johnson & Johnson (JNJ – Research ...

Approvals are coming fast and furious for Johnson & Johnson’s Rybrevant as it is lining up to challenge the dominance of ...

Cornelius Johnson, previously a wide receiver for the Los Angeles Chargers, is embarking on an exciting new chapter in his ...

After examining Johnson & Johnson, the following trends can be inferred: A Price to Earnings ratio of 24.93 significantly below the industry average by 0.75x suggests undervaluation. This can make the ...

Johnson & Johnson said the Food and Drug Administration approved its treatment of locally-advanced or metastatic non-small cell lung cancer for adults. The treatment, called Rybrevant, has been ...

So what comes next for the 54-year-old music mogul? And what about the unnamed employees and associates accused of conspiring ...

Artifacts saved from the former offices of Johnson Publishing Co. on Michigan Avenue are on display through March at the ...

The aim of this study is to investigate the relationship between workload, mental well-being and resilience among healthcare ...